BridgeMD
New treatment option for Inflammatory Bowel Disease (IBD)
Official title PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel Disease
ClinicalTrials.gov ID: NCT06758024
What this study is testing
What is Infliximab?
Infliximab is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for inflammatory bowel disease (ibd).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Infliximab (IFX) is a Food and Drug administration (FDA)-appoved monoclonal antibody medication targeting tumor necrosis factor (TNF) widely used in inflammatory bowel disease (IBD) to treat intestinal inflammation and improve patient's symptoms. Intravenous (iv) IFX is effective to treat hospitalized IBD patients with moderate-to-severe flares who fail iv corticosteroids (CS).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Adult inpatients with Crohn's disease, ulcerative colitis or inflammatory bowel disease-unclassified.
- Moderate-to-severe flare who fail to iv steroids and require infliximab as per standard of care by treating gastroenterologist
You likely can't join if
- Participant younger than 18 years
- Non-controlled infectious diseases
- Permanent ileostomy or Ileal pouch-anal anastomosis
- Pregnancy
- Patients do not consent to participate in study
- Patients unable to comply with protocol
The study team makes the final eligibility decision.
Where it's taking place
- Santiago, Chile
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Santiago, Chile. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.